Netherlands (NL)

Monte-carlo simulation of the effective lunar aperture for detection of ultra-high energy neutrinos with LOFAR (2023) Krampah GK, Buitink S, Bray JD, Corstanje A, Desmet M, Falcke H, Hare BM, et al. Journal article Near-infrared radiation induced attenuation in nested anti-resonant nodeless fibers (2023) Medaer S, Bradley TD, Francesca DD, Fu Q, Jasion G, Kuhnhenn J, Meroli S, et al. Journal article 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) (2023) Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, et al. Journal article Effects of climatic and environmental factors on mosquito population inferred from West Nile virus surveillance in Greece (2023) Ferraccioli F, Riccetti N, Fasano A, Mourelatos S, Kioutsioukis I, Stilianakis NI Journal article Design and thermodynamic analysis of a pathway enabling anaerobic production of poly-3-hydroxybutyrate in Escherichia coli (2023) Olavarria K, Becker MV, Sousa DZ, van Loosdrecht MC, Wahl SA Journal article Shared metadata for data-centric materials science (2023) Ghiringhelli LM, Baldauf C, Bereau T, Brockhauser S, Carbogno C, Chamanara J, Cozzini S, et al. Journal article Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension (2023) D'Agostino MA, Carron P, Gaillez C, Conaghan PG, Naredo E, López-Rdz A, Šenolt L, et al. Journal article Precision fermentation as a route to modify β-lactoglobulin structure through substitution of specific cysteine residues (2023) Brune SE, Hoppenreijs LJ, Kuehl T, Lautenbach V, Walter J, Peukert W, Schwarz K, et al. Journal article, Original article Evaluation of randomized controlled trials: a primer and tutorial for mental health researchers (2023) Harrer M, Cuijpers P, Schuurmans LK, Kaiser T, Buntrock C, van Straten A, Ebert D Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article